leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 01:37:28 - browse：9586

An light blue number 3 with an eye is surrounded by smaller, black number 3s on an orange background — 3 to watch coverage from STAT — Christine Kao/STAT

It’s been a slow year for medtech. Major deals in 2023 were scarce, funding was hard to come by, and valuations were down. On the policy side, the industry grappled with changing AI regulations, reimbursement woes, and device sterilization rules.

Here are three political and market forces that shaped the medtech industry last year, and are worth paying attention to in 2024:

Lobbying power of AI, software-enabled devices

Medtech lobby AdvaMed announced earlier this month that the major medical imaging companies, previously housed within the National Electrical Manufacturers Association, were shifting to their shop. The device group also created a separate niche for digital health companies in October.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

knowledge

hotspot

focus

WSS

Psychedelics group wrestles with new pharma identity

Dobbs anniversary: the lost opportunity of abortion as health care

Hepatitis C has a cure — but many Americans still lack access to it

Some dementia cases could be undiagnosed liver disease

Even great ERs can’t make up for American health disparities

DIEP, the 'gold standard' of breast reconstruction, is under threat

focus

leisure time

Lobbying power of AI, software-enabled devices

focus

Cancer drug shortages should be causing more outrage

23andMe had bad news about my health. I wish a person had delivered it

Anesthesiologist group: stop taking Ozempic before surgery

Tori Bowie and the unacceptable rates of Black maternal death

Activists slam private health insurers over coverage restrictions

Peter Hotez and the public health issue of online harassment

Peter Hotez and the public health issue of online harassment

Woodcock on FDA’s accelerated approval and her next chapter

Trump demands the U.S. pay no more for drugs than other countries … again

Congressmen charge Covid hearing ‘could have been an email’

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Peter Hotez and the public health issue of online harassment

How one medical school became remarkably diverse

New air purifier tech could be key to improving indoor air quality

New air purifier tech could be key to improving indoor air quality

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

knowledge

hotspot

focus

explore